KIORA PHARMACEUTICALS, INC. Proceeds from Sales of Assets, Investing Activities
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Sales of Assets, Investing Activities of $6.38 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSalesOfAssetsInvestingActivities · last filed 2022-11-09
- KIORA PHARMACEUTICALS, INC. proceeds from sales of assets, investing activities for the quarter ending 2022-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from sales of assets, investing activities for the quarter ending 2022-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from sales of assets, investing activities for the quarter ending 2022-03-31 was $6.38K.
| Period end | Proceeds from Sales of Assets, Investing Activities 3 month | Proceeds from Sales of Assets, Investing Activities 6 month | Proceeds from Sales of Assets, Investing Activities 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $6.38K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $6.38K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $6.38K 10-Q · filed 2022-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |